Regulatory requirements for inclusion of pharmacogenetic testing in applications for clinical trials
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Regulatory requirements for inclusion of pharmacogenetic testing in applications for clinical trials. / Due Theilade, Mette; Knudsen, Lisbeth Ehlert; Renneberg, Jan.
I: Regulatory Affairs Journal. Devices, Nr. 12 (2), 2001, s. 92-9.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Due Theilade, M, Knudsen, LE & Renneberg, J 2001, 'Regulatory requirements for inclusion of pharmacogenetic testing in applications for clinical trials', Regulatory Affairs Journal. Devices, nr. 12 (2), s. 92-9.
APA
Due Theilade, M., Knudsen, L. E., & Renneberg, J. (2001). Regulatory requirements for inclusion of pharmacogenetic testing in applications for clinical trials. Regulatory Affairs Journal. Devices, (12 (2)), 92-9.
Vancouver
Due Theilade M, Knudsen LE, Renneberg J. Regulatory requirements for inclusion of pharmacogenetic testing in applications for clinical trials. Regulatory Affairs Journal. Devices. 2001;(12 (2)):92-9.
Author
Bibtex
@article{7f364aa074c711dbbee902004c4f4f50,
title = "Regulatory requirements for inclusion of pharmacogenetic testing in applications for clinical trials",
author = "{Due Theilade}, Mette and Knudsen, {Lisbeth Ehlert} and Jan Renneberg",
year = "2001",
language = "English",
pages = "92--9",
journal = "Regulatory Affairs. Medtech",
issn = "0969-4129",
publisher = "Informa Healthcare",
number = "12 (2)",
}
RIS
TY - JOUR
T1 - Regulatory requirements for inclusion of pharmacogenetic testing in applications for clinical trials
AU - Due Theilade, Mette
AU - Knudsen, Lisbeth Ehlert
AU - Renneberg, Jan
PY - 2001
Y1 - 2001
M3 - Journal article
SP - 92
EP - 99
JO - Regulatory Affairs. Medtech
JF - Regulatory Affairs. Medtech
SN - 0969-4129
IS - 12 (2)
ER -
ID: 169661